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Conclusion: Our results suggest a lack of sympatho-vagal balance activation
in the first 5 min of tilt test in subjects with vasovagal syncope. CI and VD syn-
cope groups show a lower decrease of HF indices in the Early5. Moreover, CI
group shows a lower increase of LF indices. A perspective of this work is the
set of cut-off values from data recorded over the first 5 min of tilt test to esti-
mate the risk and the type of vasovagal reaction, based on a bigger population.
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The effect of n-3 polyunsaturated fatty acids in the pulmonary circulatory
is not well defined. This question is clinically relevant in respiratory failure
associated with pulmonary hypertension. To investigate this effect we have
realised a randomized, placebo-controlled comparative study on sixty-two
chronically prepared lamb fetuses.
Methods: Catheters and ultrasonic flow transducer were placed through a
left thoracotomy in the lamb fetus to determine aortic, pulmonary, and left
atrial pressures and left pulmonary artery blood flow. We compared the pul-
monary vascular responses to 120 min of Omegaven (lipid emulsions enriched
in n-3 polyunsaturated fatty acids) or Intralipide (lipid emulsions enriched in
n-6 polyunsaturated fatty acids) infusion. Then we investigated the effects of
Omegaven on the pulmonary circulation after nitric oxide synthase inhibition
by L-nitro-arginine, potassium channel blockade by tetraethylammonium,
cytochrome P450 epoxygenase inhibition by (methylsulfonyl)-2- (2-propyny-
loxy)-benzenehexanamide, and cyclo-oxygenase inhibition by Ibuprofen.
Results: Pulmonary artery and aortic pressures as well as blood gases and
plasma lactate concentrations did not change during either fat emulsion infusion.
Left pulmonary blood flow increased by 30% and pulmonary vascular resistance
decreased by 28% during Omegaven infusion, whereas they did not change during
Intralipide infusion. This pulmonary vascular response to Omegaven was not
altered by l-nitro-arginine or Ibuprofen infusion. At the opposite, Omegaven
induced pulmonary vasodilatation was abolished by tetraethylammonium and
markedly attenuated by (methylsulfonyl)-2- (2-propynyloxy)-benzenehexanamide.
Conclusion: Lipid emulsion containing n-3 polyunsaturated fatty acids
may induce a potent and sustained vasodilatation in the fetal lung. This pul-
monary vasodilator response is mediated through production of vasoactive
mediators by cytochrome P450 epoxygenase and through activation of potas-
sium channels.
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Background and objectives: Recent data have shown that phospholipids
(mainly phosphatidylcholine) transfer activity is associated to metabolic syn-
drom and coronary artery disease (CAD). This transfer activity could modu-
late the phosphatidylcholine (PC) distribution between lipoprotein subclasses.
In this study we separated lipoprotein fractions and we analyzed PC distribu-
tion.
Methods: Ninety two subjects were recruited (47 CAD patients and
45 age- and sex- matched controls). Antropometric measurements, lipid pro-
file and PC analysis were performed.
Results: Despite from an abnormal lipid profile: elevated serum trigly-
cerides and LDL-C, and low HDL-C (but total cholesterol level was not
significantly different between controls and CAD patients), serum PC centra-
tions were slightly higher in CAD patients than in controls (respectively
2.53±0.84 and 2.36±0.43 mmol/L, ns). The level of PC was significanly
higher in patients, compared to controls, concerning the (VLDL+LDL) frac-
tion (p<0.01). In concomitance, HDL-PC was descreased in CAD patients in
comparison with controls (p<0.05). Furthermore, serum PC level was colsely
correlated to waist/hip ratio only in CAD patients (p=0.0013). However, PC
concentrations were less closely associated to BMI in the same group
(p<0.035). 
LFnu variations (%)
between Resi5 and Early5
HFnu variations (%)
between Resi5 and Early5
-10
-20
-30
-40
-50
-60
-70
-80
-66%
+66%
+180%
400
350
300
250
200
150
100
50
0
-50
-100
p<0,01 p<0,05
-38%
NEGNEG CI CI
Mean
Mean ± SEM
Mean ± 0,95 Confidence Interval
Figure (abstract 235) – LFnu and HFnu variations (%) in EG and CI
January 19th, Saturday 2013

© Elsevier Masson SAS. All rights reserved.
 
80 Archives of Cardiovascular Diseases Supplements (2013) 5, 75-80
Conclusion: Serum phospholipid status is modulated in patients with
CAD. This involves a significant modulation of the PC distribution between
lipoprotein subclasses and probably reflects an abnormality in the phospho-
lipid transfer activity (PLTP activity) representing a useful marker of cardio-
vascular risk.
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Introduction: Coronary artery disease (CAD) is a multifactorial disease,
its expression probably being influenced by the interaction of genetic and
environmental risk factors. Genetic variation in the estrogen receptor-alpha
gene (ERS1) has been associated with CAD in several populations worldwide,
but results are still controversial. In the present study, we examined the asso-
ciation between the c.454-397T>C: PvuII restriction site (rs2234693) and
c.454-351A>G:XbaI restriction site (rs9340799) polymorphisms (SNPs) and
myocardial infarction (MI) in a sample of the Tunisian population.
Material and methods: The case group included 294 patients with MI,
and the control group comprised 275 individuals with angiographically normal
coronary arteries and without signs or symptoms of MI. ESR1 PvuII and XbaI
polymorphism was determined by polymerase chain reaction (PCR)-restriction
fragment length polymorphism (RFLP) method.
Results: Genotype distributions of the SNPs in the control and patient
groups were consistent with those expected for samples in Hardy-Weinberg
equilibrium (p> 0.05). The Genotype distribution and the relative allelic fre-
quencies of the –397T>C and – 351A>G polymorphisms were not signifi-
cantly different between the control and patient groups (p=NS). Moreover, the
odds ratio for MI associated with the c.454-397C (OR=1.02, 95% CI 0.81-
1.30), and c.454-351G (OR=1.24, 95% CI 0.98-1.58) variants failed to reach
statistical significance.
Conclusion: In the current study, we were unable to demonstrate a signif-
icant association of the ESR1 c.454-397T>C and c.454-351A>G polymor-
phisms with MI. These results do not support the extent of risk associated with
developing MI previously reported for the ESR1 c.454-397T>C and c.454-
351A>G polymorphisms.
